Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works

Wnt signaling and cancer

Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · see citing works

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works

GSK-3: tricks of the trade for a multi-tasking kinase

Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Purification and cloning of amyloid precursor protein β-secretase from human brain

Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612 · see citing works

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · see citing works

Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · see citing works

Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C. J., Munemitsu, S. M., & Polakis, P. G. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,420 · see citing works

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,394 · see citing works

Inflammation in neurodegenerative diseases

Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355 · see citing works

Untitled work

Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,200 · see citing works

Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

Harada, N., Tamai, Y., Ishikawa, T., Sauer, B., Takaku, K., Oshima, M., & Taketo, M. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5931 · Cited by 1,198 · see citing works

Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease

Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125 · see citing works

Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001 · see citing works

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Coghlan, M. P., Culbert, A. A., Cross, D. A. E., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O., Murphy, G. J., Carter, P. S., Cox, L. R., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00025-9 · Cited by 901 · see citing works

The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

Wang, W., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 827 · see citing works

BACE1 is the major β-secretase for generation of Aβ peptides by neurons

Cai, H., Wang, Y.-S., McCarthy, D., Wen, H., Borchelt, D., Price, D. L., & Wong, P. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 791 · see citing works

GSK3 inhibitors: development and therapeutic potential

Cohen, P., & Goedert, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1415 · Cited by 788 · see citing works

Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729 · see citing works

Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin

Orford, K. W., Crockett, C., Jensen, J. P., Weissman, A. M., & Byers, S. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24735 · Cited by 714 · see citing works

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration <i>in vivo</i>

Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · see citing works

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer’s disease therapeutics

Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705 · see citing works

Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703 · see citing works

Modulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation.

Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., & Woodgett, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05715.x · Cited by 630 · see citing works

Bace1 modulates myelination in the central and peripheral nervous system

Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · see citing works

Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating <i>BACE1</i> gene expression

Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · see citing works

Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice

Bromley‐Brits, K., Deng, Y., & Song, W. (2011) · Journal of Visualized Experiments · doi:10.3791/2920 · Cited by 584 · see citing works

Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease

Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · see citing works

Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418

Bhat, R. V., Xue, Y., von Berg, S., Hellberg, S., Ormö, M., Nilsson, Y., Radesäter, A., Jerning, E., Markgren, P.-O., Borgegård, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306268200 · Cited by 557 · see citing works

BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease

Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., & Disterhoft, J. F. (2004) · Neuron · doi:10.1016/s0896-6273(03)00810-9 · Cited by 549 · see citing works

GSK-3: Functional Insights from Cell Biology and Animal Models

Kaidanovich‐Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 487 · see citing works

The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf

Cross, D. A. E., Alessi, D. R., Vandenheede, J. R., McDowell, H. E., Hundal, H. S., & Cohen, P. (1994) · Biochemical Journal · doi:10.1042/bj3030021 · Cited by 474 · see citing works

Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes

Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (1999) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/00005072-199909000-00011 · Cited by 459 · see citing works

The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 439 · see citing works

Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium

Sarno, P. D., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 433 · see citing works

Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology

Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · see citing works

Increased NF-Κb Signalling Up-Regulates BACE1 Expression and its Therapeutic Potential in Alzheimer's Disease

Chen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000149 · Cited by 433 · see citing works

Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments

Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., & Imahori, K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81066-9 · Cited by 402 · see citing works

Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review

Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N. (2004) · Neuroepidemiology · doi:10.1159/000078501 · Cited by 394 · see citing works

Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

Herzig, M. C., Winkler, D. T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., Danner, S., Abramowski, D., Stürchler-Pierrat, C., Bürki, K., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1302 · Cited by 391 · see citing works

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

Cross, D. A. E., Culbert, A. A., Chalmers, K. A., Facci, L., Skaper, S. D., & Reith, A. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00251.x · Cited by 377 · see citing works

Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

Qing, H., He, G., Ly, P. T. T., Fox, C. J., Staufenbiel, M., Cai, F., Zhang, Z., Wei, S., Sun, X., Chen, C.-H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081588 · Cited by 365 · see citing works

β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365 · see citing works

Massive gliosis induced by interleukin‐6 suppresses Aβ deposition <i>in vivo:</i> evidence against inflammation as a driving force for amyloid deposition

Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328 · see citing works

Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice

Spittaels, K., den Haute, C. V., Dorpe, J. V., Geerts, H., Mercken, M. H., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 317 · see citing works

Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

Jo, J., Whitcomb, D. J., Olsen, K. M., Kerrigan, T. L., Lo, S.-C., Bru-Mercier, G., Dickinson, B., Scullion, S., Sheng, M., Collingridge, G., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2785 · Cited by 305 · see citing works

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease

Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303 · see citing works

Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice

McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 2× · see citing works

Lithium, a Common Drug for Bipolar Disorder Treatment, Regulates Amyloid-β Precursor Protein Processing

Yuan, S., Ryder, J. W., Li, B., Wu, X., Fox, N. W., Solenberg, P., Brune, K. A., Paul, S. M., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 295 · see citing works

β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain

Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T., & Irizarry, M. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63159-8 · Cited by 294 · see citing works

Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons

Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., & Yamaguchi, H. (1998) · Neuroscience Research · doi:10.1016/s0168-0102(98)00061-3 · Cited by 287 · see citing works

Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase

Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 277 · see citing works

Phosphorylation Regulates Intracellular Trafficking of β-Secretase

Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G., & Haass, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011116200 · Cited by 272 · see citing works

Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration

Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Ávila, J., Bogónez, E., & Díaz‐Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270 · see citing works

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

Eikelenboom, P., van Exel, E. R., Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & van Gool, W. A. (2010) · Neurodegenerative Diseases · doi:10.1159/000283480 · Cited by 259 · see citing works

The Cell Adhesion Protein P-selectin Glycoprotein Ligand-1 Is a Substrate for the Aspartyl Protease BACE1

Lichtenthaler, S. F., Dominguez, D.-I., Westmeyer, G. G., Reiß, K., Haass, C., Säftig, P., Strooper, B. D., & Seed, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303861200 · Cited by 256 · see citing works

The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate

Arnim, C. A. F. V., Kinoshita, A., Peltan, I. D., Tangredi, M. M., Herl, L. D., Lee, B. M., Spoelgen, R., Hshieh, T. T., Ranganathan, S., Battey, F. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414248200 · Cited by 255 · see citing works

Developmental expression and localization of glycogen synthase kinase-3β in rat brain

Leroy, K., & Brion, J. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00012-5 · Cited by 241 · see citing works

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240 · cited 1× · see citing works

Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain

Beurel, E., & Jope, R. S. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-9 · Cited by 230 · see citing works

Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimer's disease

Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., & Rivest, S. (2008) · Brain · doi:10.1093/brain/awn331 · Cited by 221 · see citing works

Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1

Li, Q., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310001200 · Cited by 219 · see citing works

Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1

Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 218 · see citing works

Wnt Signaling to β-Catenin Involves Two Interactive Components

Chen, R., Ding, W. V., & McCormick, F. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905336199 · Cited by 217 · see citing works

Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription

Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205 · see citing works

Oral administration of a potent and selective non‐peptidic BACE‐1 inhibitor decreases β‐cleavage of amyloid precursor protein and amyloid‐β production in vivo

Hussain, I., Hawkins, J., Harrison, D. C., Hille, C. J., Wayne, G. J., Cutler, L., Buck, T., Walter, D. S., Demont, E. H., Howes, C., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04260.x · Cited by 197 · see citing works

Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3

Beurel, E., & Jope, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802481200 · Cited by 189 · see citing works

Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez-Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188 · see citing works

The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

Boutajangout, A., Leroy, K., Authelet, M., Anderton, B. H., Brion, J., & Woodgett, J. R. (2002) · Acta Neuropathologica · doi:10.1007/s004010100435 · Cited by 186 · see citing works

Genetic Deletion of Glycogen Synthase Kinase-3β Abrogates Activation of IκBα Kinase, JNK, Akt, and p44/p42 MAPK but Potentiates Apoptosis Induced by Tumor Necrosis Factor

Takada, Y., Fang, X., Jamaluddin, M. S., Boyd, D. D., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403449200 · Cited by 182 · see citing works

Presenilin-1 mutations in Alzheimer's disease

Russo, C., Schettini, G., Saido, T. C., Hulette, C. M., Lippa, C. F., Lannfelt, L., Ghetti, B. F., Gambetti, P., Tabaton, M., & Teller, J. K. (2000) · Nature · doi:10.1038/35014735 · Cited by 156 · see citing works

BACE2, as a novel APP θ‐secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome

Sun, X., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5632com · Cited by 156 · see citing works

ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site

Hussain, I., Powell, D. J., Howlett, D. R., Chapman, G. A., Gilmour, L., Murdock, P. R., Tew, D. G., Meek, T. D., Chapman, C. G., Schneider, K., et al. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0884 · Cited by 156 · see citing works

BACE1 Suppression by RNA Interference in Primary Cortical Neurons

Kao, S.-C., Krichevsky, A. M., Kosik, K. S., & Tsai, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309219200 · Cited by 152 · see citing works

Degradation of BACE by the ubiquitin‐proteasome pathway

Qing, H., Zhou, W., Christensen, M. A., Sun, X., Tong, Y., & Song, W. (2004) · The FASEB Journal · doi:10.1096/fj.04-1994fje · Cited by 149 · see citing works

Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes

Sun, X., Wang, Y., Qing, H., Christensen, M. A., Liu, Y., Zhou, W., Tong, Y., Xiao, C., Huang, Y., Zhang, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3426com · Cited by 132 · see citing works

Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+.

Inhorn, R. C., & Majerus, P. W. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47680-6 · Cited by 129 · see citing works

NFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42

Buggia-Prévot, V., Sévalle, J., Roßner, S., & Checler, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706579200 · Cited by 125 · see citing works

Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription

Li, Y., Zhou, W., Tong, Y., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-4986com · Cited by 125 · see citing works

Expression of the Alzheimer protease BACE1 is suppressed via its 5'‐untranslated region

Lammich, S., Schöbel, S., Zimmer, A., Lichtenthaler, S. F., & Haass, C. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400166 · Cited by 118 · see citing works

Glycogen Synthase Kinase 3β Induces Caspase-cleaved Tau Aggregation in Situ

Cho, J., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403364200 · Cited by 116 · see citing works

Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition

Chakrabarty, P., Tianbai, L., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-36 · Cited by 116 · see citing works

GSK3β Activity Modifies the Localization and Function of Presenilin 1

Uemura, K., Kuzuya, A., Shimozono, Y., Aoyagi, N., Andō, K., Shimohama, S., & Kinoshita, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610708200 · Cited by 114 · see citing works

Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy

Arnim, C. A. F. V., Tangredi, M. M., Peltan, I. D., Lee, B. M., Irizarry, M. C., Kinoshita, A., & Hyman, B. T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01422 · Cited by 107 · see citing works

BACE (β-secretase) modulates the processing of APLP2 in vivo

Pastorino, L., Ikin, A. F., Lamprianou, S., Vacaresse, N., Revelli, J., Platt, K. A., Paganetti, P., Mathews, P. M., Harroch, S., & Buxbaum, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.013 · Cited by 106 · see citing works

Differential utilization of upstream AUGs in the β-secretase mRNA suggests that a shunting mechanism regulates translation

Rogers, G. W., Edelman, G. M., & Mauro, V. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308576101 · Cited by 91 · see citing works

Leaky Scanning and Reinitiation Regulate BACE1 Gene Expression

Zhou, W., & Song, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3353-3364.2006 · Cited by 84 · see citing works

Translational regulation of BACE-1 expression in neuronal and non-neuronal cells

Tonelli, D. D. P. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh348 · Cited by 81 · see citing works

GSK-3α/β kinases and amyloid production in vivo

Jaworski, T., Dewachter, I., Lechat, B., Gees, M., Kremer, A., Demedts, D., Borghgraef, P., Devijver, H., Kügler, S., Patel, S., et al. (2011) · Nature · doi:10.1038/nature10615 · Cited by 69 · see citing works

Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors

Nærum, L., Nørskov‐Lauritsen, L., & Olesen, P. H. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00169-5 · Cited by 66 · see citing works

Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome

Sun, X., Tong, Y., Qing, H., Chen, C.-H., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5628com · Cited by 63 · see citing works

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Ly, P. T. T., Cai, F., & Song, W. (2011) · Journal of Visualized Experiments · doi:10.3791/2831 · Cited by 63 · see citing works

Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease

Cruts, M., Dermaut, B., Rademakers, R., Roks, G., den Broeck, M. V., Munteanu, G., van Duijn, C. M., & Broeckhoven, C. V. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02234-0 · Cited by 48 · see citing works

Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice

Bromley‐Brits, K., Deng, Y., & Song, W. (2011) · Journal of Visualized Experiments · doi:10.3791/2920-v · Cited by 47 · see citing works

The binding of lithium and of anionic metabolites to phosphoglucomutase

Ray, W. J., Szymanki, E. S., & Ng, L. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90076-1 · Cited by 43 · see citing works

Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras

Gapuzan, M.-E. R., Schmah, O., Pollock, A. D., Hoffmann, A., & Gilmore, T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208809 · Cited by 41 · see citing works

Mutations in the open reading frame of the β-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease

Nicolaou, M., Song, Y., Sato, C., Orlacchio, A., Kawarai, T., Medeiros, H., Liang, Y., Sorbi, S., Richard, E., Rogaev, E. I., et al. (2001) · Neurogenetics · doi:10.1007/s100480100123 · Cited by 41 · see citing works

Association study between Alzheimer?s disease and genes involved in A? biosynthesis, aggregation and degradation: suggestive results with BACE1

Clarimón, J., Bertranpetit, J., Calafell, F., Boada, M., T�rraga, L., & Comas, D. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1127-8 · Cited by 41 · see citing works

Polymorphism in the BACE gene influences the risk for Alzheimer's disease

Kirschling, C. M., Kölsch, H., Frahnert, C., Rao, M. L., Maier, W., & Heun, R. (2003) · Neuroreport · doi:10.1097/00001756-200307010-00011 · Cited by 35 · see citing works

NF‐κB signaling inhibits ubiquitin carboxyl‐terminal hydrolase L1 gene expression

Wang, R., Zhang, M., Zhou, W., Ly, P. T. T., Cai, F., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07172.x · Cited by 34 · see citing works

The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans

Shi, J., Zhang, S., Tang, M., Liu, X., Li, T., Wang, Y., Han, H., Guo, Y., Hao, Y., Zheng, K.-Q., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20087 · Cited by 18 · see citing works

BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer’s Disease

Zhou, W., Cai, F., Li, Y., Yang, G., O’Connor, K. D., Holt, R. A., & Song, W. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9381-6 · Cited by 17 · see citing works

Scaffold Hopping and Optimization Towards Libraries of Glycogen Synthase Kinase‐3 Inhibitors.

Naerum, L., Noerskov‐Lauritsen, L., & Olesen, P. H. (2002) · ChemInform · doi:10.1002/chin.200238245

Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768 · see citing works

Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future

Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988 · see citing works

Glycogen synthase kinase-3 signaling in Alzheimer's disease

Lauretti, E., Dincer, O., & Praticò, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118664 · Cited by 624 · see citing works

Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential

Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606 · see citing works

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 493 · see citing works

GSK-3 and tau: a key duet in Alzheimer’s disease

Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314 · see citing works

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248 · see citing works

GSK-3β, a pivotal kinase in Alzheimer disease

Llorens-Marítin, M., Jurado, J., Hernández, F., & Ávila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451 · see citing works

Molecular links between Alzheimer’s disease and diabetes mellitus

Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201 · see citing works

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective

Ramakrishna, K., Nalla, L. V., Dumala, N., Venkateswarlu, K., Viswanadh, M. K., Nalluri, B. N., Chakravarthy, G., Duguluri, S., Singh, P., Nand, S., et al. (2023) · Diseases · doi:10.3390/diseases11030089 · Cited by 203 · see citing works

Long-term potentiation decay and memory loss are mediated by AMPAR endocytosis

Dong, Z., Han, H., Li, H., Bai, Y., Wang, W., Tu, M., Yan, P., Zhou, L., He, W., Wu, X., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77888 · Cited by 194 · see citing works

Shifting eating to the circadian rest phase misaligns the peripheral clocks with the master SCN clock and leads to a metabolic syndrome

Mukherji, A., Kobiita, A., Damara, M., Misra, N., Méziane, H., Champy, M., & Chambon, P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519807112 · Cited by 179 · see citing works

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

Jiao, S., Yao, X., Liu, Y.-H., Wang, Q., Zeng, F., Lu, J., Liu, J., Zhu, C., Shen, L., Liu, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422998112 · Cited by 173 · see citing works

Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments

King, M. K., Pardo, M., Cheng, Y., Downey, K., Jope, R. S., & Beurel, E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.010 · Cited by 172 · see citing works

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease

Wang, X., Zhou, X., Li, G., Zhang, Y., Wu, Y., & Song, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00294 · Cited by 173 · see citing works

Human neural stem cells alleviate Alzheimer-like pathology in a mouse model

Lee, I.-S., Jung, K., Kim, I., Lee, H.-J., Kim, M., Yun, S., Hwang, K., Shin, J. E., & Park, K. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0035-6 · Cited by 169 · see citing works

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 163 · see citing works

Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice

Yuzwa, S. A., Shan, X., Jones, B. A., Zhao, G., Woodward, M. L., Li, X., Zhu, Y., McEachern, E. J., Silverman, M. A., Watson, N. V., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-42 · Cited by 151 · see citing works

Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage

Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.012 · Cited by 147 · see citing works

Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications

Uddin, M. S., & Lim, L. W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101622 · Cited by 149 · see citing works

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective

Derry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 142 · see citing works

Lithium and Therapeutic Targeting of GSK-3

Snitow, M. E., Bhansali, R. S., & Klein, P. S. (2021) · Cells · doi:10.3390/cells10020255 · Cited by 145 · see citing works

Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease

Zhang, J., Hu, M., Teng, Z., Tang, Y., & Chen, C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1165-14.2014 · Cited by 138 · see citing works

Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo

Zhang, M., Cai, F., Zhang, S., Zhang, S., & Song, W. (2014) · Scientific Reports · doi:10.1038/srep07298 · Cited by 136 · see citing works

Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease

Lloret, A., Fuchsberger, T., Giraldo, E., & Viña, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.028 · Cited by 135 · see citing works

Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα

Chandra, S., Jana, M., & Pahan, K. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0054-18.2018 · Cited by 134 · see citing works

β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade

Zhang, F., Gannon, M., Chen, Y., Yan, S., Zhang, S., Feng, W., Tao, J., Sha, B., Liu, Z., Saito, T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay6931 · Cited by 133 · see citing works

BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis

Zhang, S., Wang, Z., Cai, F., Zhang, M., Wu, Y., Zhang, J., & Song, W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0340-17.2017 · Cited by 131 · see citing works

Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward

Ruiz, S. M. A., & Eldar-Finkelman, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.792364 · Cited by 126 · see citing works

The Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease

MacLeod, R., Hillert, E., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 131 · see citing works

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease

Zhang, Y., Dong, Z., & Song, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0145-7 · Cited by 128 · see citing works

Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset

Dionísio, P. A., Amaral, J. D., Ribeiro, M. F., Lo, A. C., D'Hooge, R., & Rodrigues, C. M. P. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.034 · Cited by 127 · see citing works

Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease

Farr, S. A., Ripley, J. L., Rukhsana Sultana, A., Zhang, Z., Niehoff, M. L., Platt, T. L., Murphy, M. P., Morley, J. E., Kumar, V. B., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.014 · Cited by 127 · see citing works

Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease

Shi, Z.-M., Han, Y.-W., Han, X.-H., Zhang, K., Chang, Y.-N., Hu, Z.-M., Qi, H.-X., Ting, C., Zhen, Z., & Hong, W. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.022 · Cited by 125 · see citing works

Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer’s Disease

Folke, J., Pakkenberg, B., & Brudek, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1103-z · Cited by 123 · see citing works

Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease

Arenas, E. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju001 · Cited by 122 · see citing works

NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease

Sivamaruthi, B. S., Raghani, N. R., Chorawala, M. R., Bhattacharya, S., Prajapati, B. G., Elossaily, G. M., & Chaiyasut, C. (2023) · Biomedicines · doi:10.3390/biomedicines11092587 · Cited by 124 · see citing works

Neurogenesis impairment: An early developmental defect in Down syndrome

Stagni, F., Giacomini, A., Emili, M., Guidi, S., & Bartesaghi, R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.026 · Cited by 120 · see citing works

MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer’s disease models

Du, Y., Du, Y., Zhang, Y., Huang, Z., Fu, M., Li, J., Pang, Y., Lei, P., Wang, Y. T., Song, W., et al. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0091-4 · Cited by 117 · see citing works

Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter

Parr, C., Mirzaei, N., Christian, M., & Sastre, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-253211 · Cited by 113 · see citing works

Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease

Hoffman, J. L., Faccidomo, S., Kim, M., Taylor, S. M., Agoglia, A. E., May, A. M., Smith, E. N., Wong, L. C., & Hodge, C. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.017 · Cited by 109 · see citing works

The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease

Gu, X., Xu, L.-J., Liu, Z., Wei, B., Yang, Y., Xu, G., Yin, X., & Wang, W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.052 · Cited by 113 · see citing works

Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective

De Simone, A., Tumiatti, V., Andrisano, V., & Milelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00931 · Cited by 110 · see citing works

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 111 · see citing works

Amyloid‐β protein (Aβ) Glu11 is the major β‐secretase site of β‐site amyloid‐β precursor protein‐cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis

Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., & Song, W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12235 · Cited by 108 · see citing works

G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs

Zhao, J., Deng, Y., Jiang, Z., & Qing, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00058 · Cited by 108 · see citing works

Cannabidiol for neurodegenerative disorders: A comprehensive review

Bhunia, S., Kolishetti, N., Yndart, A., Vashist, A., & Nair, M. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989717 · Cited by 115 · see citing works

A New Avenue for Lithium: Intervention in Traumatic Brain Injury

Leeds, P. R., Yu, F., Wang, Z., Chiu, C., Zhang, Y., Leng, Y., Linares, G. R., & Chuang, D. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500040g · Cited by 108 · see citing works

Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats

Cai, H.-Y., Hölscher, C., Yue, X.-H., Zhang, S., Wang, X.-H., Qiao, F., Yang, W., & Qi, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.022 · Cited by 106 · see citing works

Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum

Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 104 · see citing works

Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration

Rippin, I., & Eldar-Finkelman, H. (2021) · Cells · doi:10.3390/cells10020262 · Cited by 102 · see citing works

A partnership with the proteasome; the destructive nature of GSK3

Robertson, H., Hayes, J. D., & Sutherland, C. D. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.016 · Cited by 99 · see citing works

Marginal vitamin A deficiency facilitates Alzheimer’s pathogenesis

Zeng, J., Chen, L., Wang, Z., Chen, Q., Fan, Z., Jiang, H., Wu, Y.-L., Ren, L., Chen, J., Li, T.-Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1669-y · Cited by 83 · see citing works

Wnt Signaling in the Central Nervous System: New Insights in Health and Disease

Oliva, C. A., Montecinos-Oliva, C., & Inestrosa, N. C. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.018 · Cited by 97 · see citing works

Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model

Ng, R. C.-L., Jian, M., Ma, O. K.-F., Bunting, M., Kwan, J., Zhou, G.-J., Krishnamoorthi, S., Iyaswamy, A., Chan, P., Li, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0701-0 · Cited by 94 · see citing works

The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?

Bhat, R. V., Andersson, U., Andersson, S., Knerr, L., Bauer, U., & Sundgren‐Andersson, A. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179934 · Cited by 98 · see citing works

Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation

Li, C., Wang, X., Li, X., Qiu, K., Jiao, F., Liu, Y., Kong, Q., Liu, Y., & Wu, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00170 · Cited by 90 · see citing works

Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

Ege, D. (2021) · Materials · doi:10.3390/ma14123332 · Cited by 91 · see citing works

Interventions for age-related diseases: Shifting the paradigm

Figueira, I., Fernandes, A. M. A., Mladenović, A., Lopez-Contreras, A. J., Henriques, C. M., Selman, C., Ferreiro, E. B., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87 · see citing works

The Main Alkaloids in Uncaria rhynchophylla and Their Anti-Alzheimer’s Disease Mechanism Determined by a Network Pharmacology Approach

Zeng, P. H., Wang, X., Ye, C., Su, H.-F., & Tian, Q. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073612 · Cited by 88 · see citing works

Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88 · see citing works

Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration

Zhou, Q., Li, S., Li, M., Ke, D., Wang, Q., Yang, Y., Liu, G., Wang, X., Liu, E., & Wang, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103970 · Cited by 85 · see citing works

The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology

Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 85 · see citing works

Angiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathy

Yun, J.-H., Park, S. W., Kim, J. H., Park, Y., Cho, C.-H., & Kim, J. H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.347 · Cited by 85 · see citing works

Potential Neuroprotective Effects of Adiponectin in Alzheimer’s Disease

Ng, R. C.-L., & Chan, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030592 · Cited by 84 · see citing works

Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease

Nunes, M. A., Schöwe, N. M., Monteiro-Silva, K. C., Baraldi-Tornisielo, T., Souza, S. I. G., Balthazar, J., Albuquerque, M. S., Caetano, A. L., Viel, T. A., & Buck, H. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142267 · Cited by 83 · see citing works

New insight into Alzheimer's disease: Light reverses Aβ‐obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice

Yue, X., Mei, Y., Zhang, Y., Tong, Z., Cui, D., Wang, A., Wang, R., Wang, R., Fei, X., Di, Y., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.007 · Cited by 79 · see citing works

BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis

Wang, Z., Xu, Q., Cai, F., Liu, X., Wu, Y., & Song, W. (2019) · JCI Insight · doi:10.1172/jci.insight.123431 · Cited by 78 · see citing works

Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?

Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 78 · see citing works

Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer’s Disease Mortality in Texas

Fajardo, V. A., Fajardo, V. A., LeBlanc, P. J., & MacPherson, R. E. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170744 · Cited by 78 · see citing works

Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice

Zhao, Y., Chen, X., Wu, Y., Wang, Y., Li, Y., & Xiang, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00140 · Cited by 79 · see citing works

GSK3β Regulates Brain Energy Metabolism

Martin, S. A., Souder, D. C., Miller, K. N., Clark, J. P., Sagar, M. A. K., Eliceiri, K. W., Puglielli, L., Beasley, T. M., & Anderson, R. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.045 · Cited by 78 · see citing works

Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease

Tang, B. L. (2020) · Toxics · doi:10.3390/toxics8020021 · Cited by 81 · see citing works

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases

Yu, H., Xiong, M., & Zhang, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1209703 · Cited by 79 · see citing works

High Glucose Promotes Aβ Production by Inhibiting APP Degradation

Yang, Y., Wu, Y., Zhang, S., & Song, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069824 · Cited by 77 · see citing works

A unique type of GSK-3 inhibitor brings new opportunities to the clinic

Licht-Murava, A., Paz, R., Vaks, L., Avrahami, L., Plotkin, B., Eisenstein, M., & Eldar-Finkelman, H. (2016) · Science Signaling · doi:10.1126/scisignal.aah7102 · Cited by 77 · see citing works

When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease

D’Mello, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115911 · Cited by 77 · see citing works

Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease

Zhang, S., Zhao, J., Zhang, Y., Zhang, Y., Cai, F., Wang, L., & Song, W. (2019) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-019-0508-x · Cited by 73 · see citing works

USP25 inhibition ameliorates Alzheimer’s pathology through the regulation of APP processing and Aβ generation

Zheng, Q., Song, B., Li, G., Cai, F., Wu, M., Zhao, Y., Jiang, L., Guo, T., Shen, M., Hou, H., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152170 · Cited by 73 · see citing works

Melatonin: A potential nighttime guardian against Alzheimer’s

Zhang, Z., Xue, P., Bendlin, B. B., Zetterberg, H., Felice, F. G. D., Tan, X. W., & Benedict, C. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02691-6 · Cited by 74 · see citing works

The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-β Production and Tau Hyperphosphorylation

Paris, D., Ait-Ghezala, G., Bachmeier, C., Laco, G., Beaulieu-Abdelahad, D., Lin, Y., Jin, C., Crawford, F., & Mullan, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608091 · Cited by 73 · see citing works

Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms

Du, Y., Qu, J., Zhang, W., Bai, M., Zhou, Q., Zhang, Z., Li, Z., & Miao, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.008 · Cited by 72 · see citing works

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease

Shri, S. R., Manandhar, S., Nayak, Y., & Pai, K. S. R. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.071 · Cited by 71 · see citing works

Recent advances in drug repurposing using machine learning

Urbina, F., Puhl, A. C., & Ekins, S. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.06.001 · Cited by 71 · see citing works

Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer’s disease.

Qian, Q., Zhang, J., He, F.-P., Bao, W.-X., Zheng, T.-T., Zhou, D.-M., Pan, H.-Y., Zhang, H., Zhang, X.-Q., He, X., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801846r · Cited by 70 · see citing works

Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes

Huang, D., Yu, M., Yang, S., Lou, D., Zhou, W., Zheng, L., Wang, Z., Cai, F., Zhou, W., Li, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0703-3 · Cited by 70 · see citing works

Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer’s Disease Patients

Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 72 · see citing works

Peripheral Inflammation and Insulin Resistance: Their Impact on Blood–Brain Barrier Integrity and Glia Activation in Alzheimer’s Disease

Ponce-Lopez, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094209 · Cited by 75 · see citing works

miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways

Jiang, H., Liu, J., Guo, S., Zeng, L., Cai, Z., Zhang, J., Wang, L., Li, Z., & Liu, R. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.008 · Cited by 69 · see citing works

3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease

Prati, F., Simone, A. D., Armirotti, A., Summa, M., Pizzirani, D., Scarpelli, R., Bertozzi, S. M., Pérez, D. I., Andrisano, V., Pérez‐Castillo, A., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00121 · Cited by 68 · see citing works

Low-Frequency Repetitive Transcranial Magnetic Stimulation Ameliorates Cognitive Function and Synaptic Plasticity in APP23/PS45 Mouse Model of Alzheimer’s Disease

Huang, Z., Tan, T., Du, Y., Chen, L., Fu, M., Yu, Y., Zhang, L., Song, W., & Dong, Z. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00292 · Cited by 67 · see citing works

A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling

Zhang, S., Cai, F., Wu, Y., Bozorgmehr, T., Wang, Z., Zhang, S., Huang, D., Guo, J., Shen, L., Rankin, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0101-x · Cited by 66 · see citing works

Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis

Huang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh‐Li, H. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03426-8 · Cited by 64 · see citing works

The Association Between Folate and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhang, X., Bao, G., Liu, D., Yu, Y., Li, X., Cai, G., Liu, Y., & Wu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.661198 · Cited by 65 · see citing works

Melatonin ameliorates Aβ42‐induced alteration of β APP ‐processing secretases via the melatonin receptor through the Pin1/ GSK 3β/ NF ‐κB pathway in SH ‐ SY 5Y cells

Chinchalongporn, V., Shukla, M., & Govitrapong, P. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12470 · Cited by 66 · see citing works

Formaldehyde induces diabetes‐associated cognitive impairments

Tan, T., Zhang, Y., Luo, W., Lv, J., Han, C., Hamlin, J. N. R., Luo, H., Li, H., Wan, Y., Yang, X., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701239r · Cited by 63 · see citing works

Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity

Jantrapirom, S., Nimlamool, W., Chattipakorn, N., Chattipakorn, S. C., Temviriyanukul, P., Inthachat, W., Govitrapong, P., & Potikanond, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051725 · Cited by 63 · see citing works

Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice

Zhang, Y., Chen, H., Feng, Y., Liu, M., Lu, Z., Hu, B., Chen, L., Zhang, Y., Liu, J., Cai, F., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00869-3 · Cited by 64 · see citing works

Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders

O’Leary, O. F., & Nolan, Y. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0213-z · Cited by 63 · see citing works

Identification of novel small molecules against GSK3β for Alzheimer's disease using chemoinformatics approach

Shukla, R., Munjal, N. S., & Singh, T. R. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.06.008 · Cited by 62 · see citing works

O1‐06‐06: Regulation of BACE1 expression by GSK3‐beta and its therapeutic effect on Alzheimer's disease

Ly, P. T. T., Wu, Y., & Song, W. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.238

Glycogen synthase kinase-3 signaling in Alzheimer's disease : regulation of beta-amyloid precursor protein processing and amyloid beta protein production

Ly, P. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0072944 · Cited by 1 · see citing works

Cellular and molecular mechanisms by which specific GSK3 inhibition affects the processing of the Amyloid Precursor Protein

Sastre, M., & Parr, C. J. C. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique)

Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease

Cai, Z., Zhao, Y. C., & Zhao, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455386 · Cited by 146 · see citing works

Down-Regulation of Amyloid-β Through AMPK Activation by Inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 Cells

Cai, Z., Li, B., Li, K., & Zhao, B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111649 · Cited by 32 · see citing works